Literature DB >> 6857581

Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung.

H W Mooren, J A Kramps, C Franken, C J Meijer, J A Dijkman.   

Abstract

The localisation of a low-molecular-weight bronchial protease inhibitor (LMI) in human peripheral lung tissue was studied by an immunohistochemical method. This inhibitor was found exclusively in a part of the non-ciliated cell population of the bronchiolar epithelium. An inverse relationship was observed between the number of LMI-positive non-ciliated cells per millimetre of basement membrane and the bronchiolar diameter. These findings may have a bearing on the protease-antiprotease theory of the development of pulmonary emphysema, LMI possibly playing a part in the protection of peripheral lung tissue against proteolytic destruction by enzymes liberated from granulocytes or migrating alveolar macrophages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6857581      PMCID: PMC459515          DOI: 10.1136/thx.38.3.180

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  The distribution of muramidase (lysozyme) in human tissues.

Authors:  D Y Mason; C R Taylor
Journal:  J Clin Pathol       Date:  1975-02       Impact factor: 3.411

2.  Ultrastructural immunocytochemical localisation of lysozyme in human bronchial glands.

Authors:  D Bowes; B Corrin
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

3.  Pathologic changes in the peripheral airways of young cigarette smokers.

Authors:  D E Niewoehner; J Kleinerman; D B Rice
Journal:  N Engl J Med       Date:  1974-10-10       Impact factor: 91.245

4.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

5.  [Isolation and characterisation of a protease inhibitor from human bronchial secretion].

Authors:  K Hochstrasser; R Reichert; S Schwarz; E Werle
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-02

6.  Ultrastructural localization of phospholipases in the Clara cell of the rat bronchiole.

Authors:  K Yoneda
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

7.  Tissue distribution of lysozyme in man.

Authors:  M Klockars; S Reitamo
Journal:  J Histochem Cytochem       Date:  1975-12       Impact factor: 2.479

8.  Proteases and protease inhibitors in chronic obstructive lung disease.

Authors:  S Erikson
Journal:  Acta Med Scand       Date:  1978

9.  Mechanism by which cigarette smoke attracts polymorphonuclear leukocytes to lung.

Authors:  G Hunninghake; J Gadek; R Crystal
Journal:  Chest       Date:  1980-02       Impact factor: 9.410

10.  Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor.

Authors:  K Ohlsson; H Tegner
Journal:  Scand J Clin Lab Invest       Date:  1976-09       Impact factor: 1.713

View more
  17 in total

1.  Urethral cytokine and immune responses in Chlamydia trachomatis-infected males.

Authors:  M S Pate; S R Hedges; D A Sibley; M W Russell; E W Hook; J Mestecky
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Expression of the secretory leukoprotease inhibitor gene in epithelial cells.

Authors:  T Abe; N Kobayashi; K Yoshimura; B C Trapnell; H Kim; R C Hubbard; M T Brewer; R C Thompson; R G Crystal
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

4.  Antileucoprotease in the developing fetal lung.

Authors:  L N Willems; J A Kramps; P K Jeffery; J H Dijkman
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

5.  Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples.

Authors:  H M Morrison; J A Kramps; J H Dijkman; R A Stockley
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

6.  The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.

Authors:  Aileen Gibbons; Danielle Padilla-Carlin; Ciara Kelly; Anthony J Hickey; Clifford Taggart; Noel G McElvaney; Sally-Ann Cryan
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

7.  Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Authors:  C Vogelmeier; R C Hubbard; G A Fells; H P Schnebli; R C Thompson; H Fritz; R G Crystal
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.

Authors:  P Renesto; V Balloy; T Kamimura; K Masuda; A Imaizumi; M Chignard
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

10.  Purification, characterization and proteinase-inhibitory activity of a Clara-cell secretory protein from the pulmonary extracellular lining of rabbits.

Authors:  R P Gupta; S E Patton; A M Jetten; G E Hook
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.